Recombinant Human Erythropoietin Alfa (4000iu)
Transfer 4000 IU/ml Injection is used in the treatment of anemia due to chronic kidney disease and anemia due to chemotherapy.
1 ml in 1 prefilled syringe
Bioniche Life Sciences Inc
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Your doctor or nurse will give you this medicine. Kindly do not self administer.
Transfer 4000 IU/ml Injection is an erythropoiesis-stimulating agent (ESA). It works by stimulating the bone marrow (soft tissue inside the bones which produces red blood cells) to produce more red blood cells.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Transfer 4000 IU/ml Injection may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Transfer 4000 IU/ml Injection is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Transfer 4000 IU/ml Injection may cause side effects which could affect your ability to drive.
Transfer 4000 IU/ml Injection is safe to use in patients with kidney disease. No dose adjustment of Transfer 4000 IU/ml Injection is recommended.
Regular monitoring of kidney function tests is advised while the patient is taking this medicine.
Transfer 4000 IU/ml Injection should be used with caution in patients with liver disease. Dose adjustment of Transfer 4000 IU/ml Injection may be needed. Please consult your doctor.
